Industry News
Indoor Tanning Strong Risk Factor For Skin Cancer In Young People
Dec 14, 2011
Compared to those who have never used it, young people who use indoor tanning have a 69% higher risk of developing a type of skin cancer called basal cell carcinoma (BCC), according to a new study led by researchers from the Yale School of Public Health in the US that was published online on 12 December in the Journal of the American Academy of Dermatology... Read More
Landmark Gene Therapy Clinical Trial For Hemophilia B: Commentary And Podcast
Dec 14, 2011
A recent article in the New England Journal of Medicine showed that Factor IX gene therapy in patients with hemophilia B was able to convert severe hemophilia to moderate or even mild disease... Read More
Researchers Find Potential Target For Treating Metastatic Cancer
Dec 14, 2011
Finding ways to counteract or disrupt the invasive nature of cancer cells, called "metastasis," has been a long-term goal of cancer researchers. Now, researchers at Moffitt Cancer Center in Tampa, Fla., have identified an interactive pathway that regulates metastases in some cancers that may be vulnerable to chemical targeting in order to prevent cancer cell proliferation and tumor growth... Read More
Patients With Limited-Stage Hodgkin's Lymphoma Have Increased Survival Rates When Treated With Chemotherapy Alone
Dec 14, 2011
New research led by the NCIC Clinical Trials Group (CTG) at Queen's University has proven patients with limited stage Hodgkin's lymphoma have a better chance of long-term survival if they undergo a standard chemotherapy regimen as opposed to radiation-based treatment... Read More
A High Risk Of Recurrence In Some Older Acute-Leukemia Patients Signaled By Gene Mutation
Dec 14, 2011
Older people with acute myeloid leukemia and normal looking chromosomes in their cancer cells have a higher risk of recurrence if they have mutations in a gene called ASXL1, according to a new study by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James)... Read More
Chronic Lymphocytic Leukemia Patients May Benefit From Novel Export-Inhibitor
Dec 14, 2011
An experimental drug that works by blocking the export of key control molecules from the nucleus of cancer cells shows promise as a treatment for chronic lymphocytic leukemia (CLL) and other incurable B-cell malignancies, according to a new study by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J... Read More
Treatment Decisions In Chronic Lymphocytic Leukemia Aided By Massive DNA Search
Dec 14, 2011
The most comprehensive search to date of DNA abnormalities in chronic lymphocytic leukemia (CLL) has unearthed several new altered genes that drive this common blood cancer, a finding that could potentially help doctors predict whether an individual patient's disease will progress rapidly or remain indolent for years, say scientists from Dana-Farber Cancer Institute and the Broad Institute... Read More
Shedding Light On Lymphoma Evolution With The Help Of Two Sisters
Dec 14, 2011
When a 41-year-old woman was diagnosed with chronic-phase chronic myeloid leukemia, she received a bone marrow transplant and subsequent leukocyte infusion from her sister. These treatments controlled her leukemia, but seven years later, both sisters developed follicular lymphoma... Read More
A New Way To Target Cancer Through Manipulating A Master Switch Responsible For Cancer Cell Growth
Dec 14, 2011
Scientists have discovered a new way to target cancer through manipulating a master switch responsible for cancer cell growth. The findings, published in the journal Cancer Cell, reveal how cancer cells grow faster by producing their own blood vessels... Read More
Myelofibrosis Symptoms Reduced By Ruxolinitib
Dec 14, 2011
In a major advance in treatment, a multicenter study found that ruxolinitib did a better job than off-label chemotherapy drugs reducing the terrible symptoms associated with myelofibrosis, including pain, enlarged spleen, anemia, fever, chills, fatigue, and weight loss. The results were presented at the annual meeting of the American Society of Hematology and Oncology in San Diego... Read More
Previous Page Next Page